Cardio-Oncology Research Center

visits:8

 

Cardio-Oncology Research Center

This research center was approved in December 2019 (Azar 1398).
Cardio-oncology is an interdisciplinary field combining cardiology (heart and vascular medicine) and oncology (cancer science). Due to the significant and vital effects of various cancers—especially their treatments (chemotherapy, radiotherapy, immunotherapy, and other novel therapies)—on the cardiovascular system, this field holds special importance.

This interdisciplinary science is responsible for research, prevention, support in treatment, follow-up, and care of patients with cancer or a history of cancer who also have cardiovascular disease.

Today, with the increasing prevalence of cancer and cardiovascular diseases, along with the wide variety of anticancer drugs that often have greater cardiac side effects—as well as population aging, and the rise of cardiovascular risk factors—collaboration and interaction between oncologists and cardiologists, as well as applied research and preventive and therapeutic actions in cancer patients, have become essential.

Cardio-oncology has been designed to empower cardiology specialists in applied research, prevention, assessment, and management of cardiovascular complications in cancer patients, through the use of modern knowledge and technologies—primarily based on advanced echocardiography.

The founding board members of this research center are as follows:

Azin Alizadehasl  , MD

Farzaneh Ashrafi , MD

Maryam Honardost , MD

Payam Azadeh , MD

Seyed Mohsen Razavi, MD

Bahram Mohebbi, MD

Mohammad Faranoush, MD

Deputy Director of this research center:

Seyedeh Fatemeh Hosseini Jebelli, MD

Cardio-oncology is an interdisciplinary field that combines cardiology (the study of the heart and vascular system) and oncology (the study of cancer). It has emerged due to the significant, inevitable, and often life-threatening effects of various cancers—and particularly their common treatments (such as chemotherapy, radiotherapy, immunotherapy, and other modern therapies)—on the cardiovascular system.

This multidisciplinary field focuses on research, follow-up, treatment, and long-term care of patients with cancer or a history of cancer who also suffer from cardiovascular diseases.

Today, with the increasing prevalence of both cancer and cardiovascular diseases, along with the growing variety of anticancer drugs—many of which have significant cardiotoxic effects—an aging population, and the rising incidence of cardiovascular risk factors, close collaboration between oncologists and cardiologists has become essential. This collaboration allows for more complex preventive and therapeutic strategies for patients with cancer.

Cardio-oncology has been developed to empower cardiologists with the knowledge and skills necessary to evaluate, treat, prevent, and monitor cardiovascular complications in cancer patients, using modern knowledge and technologies (primarily based on advanced echocardiography).

Cardiovascular diseases and cancer are among the leading threats to human health, and many risk factors and biological mechanisms are shared between them. With the advancement of cancer treatments, patients are living longer, but as a result, cardiovascular complications (potentially involving all components of the heart and vascular system) have become more common.

This has paved the way for more comprehensive studies. With a deeper understanding of the diverse cardiovascular complications, an aging population, increased risk factors, and the introduction of more cardiotoxic anticancer drugs—alongside the growing prevalence of both cancer and heart disease—the field of cardio-oncology was established. Its main goals are to reduce the cardiovascular complications of cancer treatment, improve cardiac and vascular function, enhance patients’ quality of life, and decrease morbidity and mortality related to cardiotoxicity.

Affiliation:

Cardio-Oncology Research Center, Rajaie Cardiovascular Institute, Tehran, Iran

 

 

International Proposals:

 

  • Echocardiographic Correlates of In-Hospital Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study
  • Ventricular Changes in Patients with Acute COVID-19 Infection: Follow-up of the World Alliance Societies of Echocardiography (WASE-COVID) Study
  • The Global Cardio-Oncology Registry (G-COR) US Pilot Study: Early cohort breast cancer patients demographics and exercise habits

Data Registry Project:

 

  • Cardiac Mass Data Registry of Patients Referred to Rajaei Cardiovascular Institute (since 2023)
  • Cardio-Oncology Toxicity Registry (COT Registry) In IRAN

Purposes:

  • Improving the quantity and quality of the center’s research activities.
  • Increasing the publication of articles in reputable national and international journals.
  • Promoting the growth of scientific production and strengthening the center’s and personnel’s capabilities.
  • Preparing and publishing reference materials on cardio-oncology at national and international levels.
  • Conducting joint research projects with other research centers.
  • Establishing active collaboration with related specialties and disciplines, including hematology-oncology and radiation oncology centers.
  • Identifying fundamental and applied research priorities and addressing them effectively.
  • Producing indigenous scientific knowledge and conducting national research aligned with the latest global advancements.
  • Organizing educational and research workshops and promoting knowledge translation.

 

 

Cardio-Oncology Books            Cardio-Oncology Research